Daily Newsletter

25 September 2023

Daily Newsletter

25 September 2023

Stamford rolls out palliative care programme at Bennett Cancer Center

It offers comprehensive care for patients with serious illnesses, aiming to relieve pain and symptoms.

September 22 2023

US-based non-profit independent health care system Stamford Health has re-introduced a palliative care programme at the Carl & Dorothy Bennett Cancer Center.

Financed in part by the Kanarek Family Foundation and Robin Bennett Kanarek, the new programme will expand on the existing palliative care offerings.

It offers comprehensive care for patients with serious illnesses, aiming to relieve pain and symptoms.

Stamford Health palliative care medical director Sherry Ng said: “Our expert palliative care providers create a layer of support to improve quality of life and help patients manage all facets of living with a serious illness.

“Palliative care is such an important part of the patient experience.

“Our new programme ensures our patients receive comprehensive care across the inpatient and outpatient setting.”

Headed by Sherry Ng, the programme is said to include a team of experienced doctors and nurse practitioners who specialise in pain management and support for patients dealing with serious illnesses.

It provides various services, such as symptom relief, advanced care planning, and emotional support.

Stamford Health collaborated with Dana-Farber Brigham Cancer Center in developing this programme.

Stamford Health spiritual care manager ReBecca Sala said: “Spiritual care is unique for each individual.

“Everyone deserves peace, healing, and support as they go through treatment.

“Our team of chaplains supports all our patients, with a special focus on palliative care patients. Our team hopes to improve their mental, physical, and spiritual health.”

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Primarily due to COVID-19, the healthcare sector has witnessed an acceleration in digital transformation, which has improved efficiencies and enhanced patient outcomes. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close